Podchaser Logo
Home
On the Forefront of NSCLC Treatment: Targeting RET Mutations

On the Forefront of NSCLC Treatment: Targeting RET Mutations

Released Tuesday, 29th September 2020
Good episode? Give it some love!
On the Forefront of NSCLC Treatment: Targeting RET Mutations

On the Forefront of NSCLC Treatment: Targeting RET Mutations

On the Forefront of NSCLC Treatment: Targeting RET Mutations

On the Forefront of NSCLC Treatment: Targeting RET Mutations

Tuesday, 29th September 2020
Good episode? Give it some love!
Rate Episode

Guest: Deepa Rangachari, MD

With newly approved therapies on the rise, the way we treat non-small cell lung cancer patients with a RET gene rearrangement may be evolving. That’s why it’s so important to test for RET mutations in patients with non-small cell lung cancer, as oncologist Dr. Deepa Rangachari explains.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features